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Scott W. Menzies1
We recently described an in vivo reflectance confocal microscopy (RCM) method and our aim was to evaluate a
possible additive value of this type of analysis in the management of melanocytic lesions. In two referral centers
(Sydney and Modena), lesions (203 nevi and 123 melanomas (MMs) with a median Breslow thickness of 0.54mm)
were excised on the basis of clinical suspicion (history, dermoscopy examination, and/or digital monitoring).
The RCM method was also trialed on a non-biopsied population of 100 lesions, which were clinically and
dermoscopically diagnosed as benign nevi. All RCM and dermoscopy diagnoses were performed blinded to the
histopathological diagnosis. Firstly, in the study population, a high interobserver agreement (on a subset of 90
lesions) was seen with the RCM method, which had superior specificity (68%, 95% confidence interval (95% CI):
61.1–74.3) for the diagnosis of MM compared with dermoscopy (32%, 95% CI: 25.9–38.7), while showing no
difference in sensitivity (91%, 95% CI: 84.6–95.5, RCM; 88%, 95% CI: 80.7–92.6 dermoscopy). The two techniques
had a weak correlation, resulting in only 2.4% of MMs being misclassified by both techniques. Diagnosis of
light-colored lesions is improved by RCM (specificity 84%, 95% CI: 66.3–94.5) compared with dermoscopy
(specificity 39%, 95% CI: 23.7–56.2). Secondly, the RCM method classified 100% of the non-biopsied control nevi
population as benign.
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INTRODUCTION
A noninvasive test, which can detect melanoma (MM) during
the curable stages and also decrease unnecessary biopsies,
would be desirable.
Dermoscopy has been proposed as the current routine
examination technique for diagnosing pigmented skin lesions
(Menzies and Zalaudek 2006). A meta-analysis of 13 studies
(Kittler et al., 2002), involving primarily specialist clinicians,
showed that the diagnostic accuracy was significantly higher
with dermoscopy than with naked eye examination (log odds
ratio (OR) 4.0 (95% confidence interval (95% CI), 3.0–5.1)
and 2.7 (1.9–3.4), respectively). Although these studies
suggested that dermoscopy had a greater impact on
sensitivity for the diagnosis of MM, a randomized trial
showed a 42% reduction in the number of patients referred
for biopsy in the dermoscopy arm (Carli et al., 2004a). This
was consistent with the finding of a significant reduction in
the benign–malignant ratio of excised melanocytic lesions
from 18:1 to 4:1 (pre- and post-dermoscopy eras, respec-
tively) (Carli et al., 2004b). However, the presence of benign
lesions with dermoscopic aspects indistinguishable from
MMs and of MMs lacking specific dermoscopic features
(Menzies et al., 1996; Pizzichetta et al. 2004) suggest the
need for diagnostic improvement.
The ability of in vivo reflectance confocal microscopy
(RCM) to obtain optical sections within the depth of intact
tissue has made this technique ideally suited to the study of
skin. Because melanin/melanosomes are refractile at near
infrared wavelengths, melanocytic-derived cells are easily
visualized (Rajadhyaksha et al., 1995). RCM has been
described in small series and selected images as an effective
method for the diagnosis of melanocytic lesions (Langley
et al., 2001; Busam et al., 2002; Marghoob et al., 2005;
Gerger et al., 2005, 2006). Preliminary studies have
shown specific RCM features of MMs and nevi that improve
the diagnostic accuracy for melanocytic lesions that are
difficult to diagnose (Pellacani et al., 2005, 2007). The
aim of this study was to investigate a possible additive value
of RCM analysis in the management of melanocytic skin
lesions.
RESULTS
During the lesion recruitment period between September
2004 to August 2007, no patient declined to have images
taken with the two techniques (RCM and dermoscopy).
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Because of the non-invasive nature of these techniques, no
adverse events occurred.
In the study population (see characteristics Table 1), a very
good interobserver correlation occurred for the diagnosis of
MM with the RCM method on a sample of 90 lesions
(K¼0.82), with agreement in 46 out of 50 (92%) MMs and 36
out of 40 (90%) benign lesions between two blinded
observers. Overall, the sensitivity and specificity for the
diagnosis of MM with dermoscopy and RCM are described in
Table 2. There was no significant difference in the
sensitivities between the two techniques; however, their
specificities differed significantly (32 and 68%, respectively,
for dermoscopy and RCM Po0.01) (Figures 1 and 2).
Significant differences were observed in OR for the diagnosis
of MM when the test was positive for malignancy, with 3.4
(95% CI: 1.8–6.3) for dermoscopy and 27.5 (95% CI:
14.5–52.3) for RCM. A total of 15 MMs (12%) were
misclassified by dermoscopy. These had a median Breslow
thickness of 0.00mm (range: 0–2.2mm), of which eight were
in situ, six superficial spreading, and one was nodular MM.
Eleven MMs (9%) were misclassified by the RCM method,
with a median Breslow thickness of 0mm (range: 0–1mm), of
which six were in situ and five superficial spreading. There
was no significant difference in the median Breslow thickness
of the false-negative MMs between the two techniques
(P¼0.67).
The sensitivity and specificity for the diagnosis of MM
of dermoscopy and RCM, as compared with the lesions
recruited in Sydney and Modena, are described in Table 3.
The dermoscopy diagnostic accuracy by pattern analysis
method in Modena and Sydney was similar (P¼ 0.68), with
both displaying a low specificity, because many of the lesions
were selected to be excised, having dermoscopy features of
MM (see Materials and Methods). The specificity of the
RCM method in the Modena population was lower than in
Sydney (Po0.001). It was, in part, influenced by the higher
proportion of dermoscopic equivocal Spitz nevi in Modena
(see Table 1), which were misclassified in 21 out of 25 cases
by RCM (Table 4). With the RCM method, there was a
significant difference in the diagnostic specificity for
Table 1. Population characteristics (study biopsied set)
Total Modena Sydney
Sex
Female/male 149/177 95/100 54/77
Age (years)
Median (IQ 25–75)1 47 (36–60) 42 (32–59) 52 (40–63)
Range 7–90 7–88 19–90
MM 123 79 44
Breslow thickness median (IQ 25–75)1 and range in mm 0.54 (0–0.98) 0.65 (0.23–1.01) 0.4 (0–0.84)
0–4 0–4 0–2.8
In situ/superficial spreading/nodular 34/86/3 18/59/2 16/27/1
Color: light/pigmented 13 (11%)/110 6 (8%)2/73 7 (16%)2/37
Nevi 203 116 87
Junctional/compound/dermal/Spitz 42/127/9/25 16/78/0/223 26/49/9/33
Color: light/pigmented 31 (15%)/172 9 (8%)2/107 22 (25%)2/65
MM, melanoma.
1IQ, interquartile 25 and 75%.
2There was a significant increase in light-colored lesions in the Sydney population (Po0.001).
3Frequency of Spitz nevi was significantly different in the two subpopulations (P=0.003).
Table 2. Diagnostic accuracy of dermoscopy and
RCM methods for the study (biopsied) set
Diagnosed as
benign by
dermoscopy
Diagnosed as
MM by
dermoscopy
Diagnosed as
benign by
RCM
Diagnosed
as MM by
RCM
Nevus
(203)
65 138 138 65
32%1 68% 68%1 32%
MM
(123)
15 108 11 112
12.2% 88% 8.9% 91%
OR
(95%
CI)
3.4 (1.8–6.3)2 27.5
(14.5–52.3)2
CI, confidence interval; MM, melanoma; OR, odds ratio; RCM,
reflectance confocal microscopy.
1Specificities of the two methods were significantly different (Po0.01).
2OR (95% CIs) for the diagnosis of MM when the method diagnosed the
lesion as malignant were significantly different between RCM and
dermoscopy (Po0.01).
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non-Spitz nevi and Spitz nevi (Po0.001). The increased
proportion of pigmented/light-colored lesions in Modena also
contributed to the poorer RCM specificity (see below).
A weak correlation between dermoscopy and RCM
diagnoses allowed improved sensitivity for MM diagnosis
by combining the two methods (Table 5). The sensitivity
increased to 98% (with only 3 MMs out of 123 being double
negative), but the specificity decreased to 22.7% (46 nevi out
of 203 were double negative). The sensitivity of the two
methods did not differ as a function of Breslow thickness or of
the pathology type of MM (data not shown). However, as
shown in Table 6, lesion color had a diagnostic impact
on both methods. For light or amelanotic-colored lesions
(31 nevi and 13 MMs), the specificity for MM diagnosis
was 39% for dermoscopy and 84% for RCM (Po0.001). RCM
specificity for light-colored lesions was significantly better
than the specificity for pigmented ones (65%, Po0.001)
(Figure 3). Two out of 13 light-colored MMs were mis-
classified by RCM. They were superficial spreading MMs with
0.87 and 1.04mm Breslow thickness. Five out of 31 light-
colored nevi were misclassified, comprising 3 compound and
2 Spitz nevi.
Finally, the RCM method for non-suspicious melanocytic
lesions (100 non-biopsied control nevi with a clinical and
dermoscopy examination of typical benign nevi) classified
100% as benign. Of these, 97 non-biopsied control nevi had
an RCM score of 0, two had a score of 1, and one a score of 2.
DISCUSSION
RCM was described in small series as a potentially effective
method for the diagnosis of melanocytic lesions (Langley
et al., 2001; Busam et al., 2002; Marghoob et al., 2005;
a
b
50 µm
Figure 1. Dermoscopy and RCM imaging. (a) Dermoscopy image of an
8-mm-diameter lesion on the arm of a 53-year-old female with an
eccentric darker focus suspicious of melanoma with focal broadening of
the pigment network. (b) In vivo confocal microscopy image of the dark
focus with regular bright-pigmented cells around dark dermal papillae
at the dermal–epidermal junction, RCM score¼ 0. Diagnosis: lentiginous
junctional nevus with mild dysplastic features.
a
b
Figure 2. Dermoscopy and RCM imaging. (a) Dermoscopy image of a
4-mm-diameter lesion on the back of a 68-year-old male with no positive
features of melanoma. (b) In vivo confocal microscopy image of large,
bright atypical-nucleated pigmented cells (arrows) in a disorganized
epidermis and non-edged dermal papillae (arrowheads), RCM score¼ 4.
Diagnosis: melanoma of 0.4mm Breslow thickness.
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Gerger et al., 2005, 2006). The method described by
Pellacani et al. is simple, with only six morphological
features scored and, was highly reproducible in our study
with 91.1% of lesions showing diagnostic concordance
between two blinded observers. Recently, this method was
shown to be diagnostically equivalent to more complex RCM
algorithms in sample sizes larger than originally described
(Pellacani et al., 2005, 2007).
The lesions examined in this study population showed
12.2% of MMs lacking dermoscopic features of MM and
68% of nevi displaying dermoscopic features suggestive of
malignancy. A history of change allowed the identification of
the dermoscopically featureless MMs, as reported previously
with digital monitoring (Kittler et al., 2006). With nearly the
same sensitivity for the diagnosis of MM (91%) as dermo-
scopy, the RCM method achieved more than double the
specificity on this population of equivocal melanocytic
lesions.
The design of this study was to evaluate the role of RCM
in a standard clinical setting. The lesions recruited for the
study were diagnosed by a clinician, followed by RCM
imaging guided by the clinical information (in some cases,
by particular areas of atypia under dermoscopy). In that
sense, the two methods are not independent. Notably, blind
imaging with RCM would clearly be less diagnostically
accurate, as shown with blind histopathological examination
compared with that aided by dermoscopy (Bauer et al.,
2001). Subsequent to this imaging, RCM diagnosis was
performed blinded to all clinical and dermoscopy informa-
tion, except age and site. This allows an independent
diagnosis to be performed while mimicking normal clinical
procedures.
Because many lesions were selected for recruitment by
dermoscopy examination, a definitive comparison of RCM
and dermoscopy is not possible with our design. Such a direct
comparison between the two techniques could be achieved
by selecting lesions by naked eye examination and then
applying both methods. However, as dermoscopy has been
shown to have a superior diagnostic accuracy as compared
Table 3. The sensitivity and specificity for the
diagnosis of MM of dermoscopy (pattern analysis) and
RCM in lesions from Sydney and Modena (study
biopsied set)
Diagnosed
as benign by
dermoscopy
Diagnosed
as MM by
dermoscopy
Diagnosed
as benign
by RCM
Diagnosed
as MM by
RCM
Sydney
Nevus (87) 32 55 71 16
37%1 63% 82%2 18%
MM (44) 4 40 4 40
9% 91%3 9% 91%
Modena
Nevus (116) 33 83 67 49
28%1 72% 58%2 42%
MM (79) 11 68 7 72
14% 86%3 9% 91%
MM, melanoma; RCM, reflectance confocal microscopy.
1There was no significant difference in dermoscopy specificity (P=0.226)
for MM between Sydney and Modena-recruited lesions.
2There was a significant reduction in RCM specificity in lesions recruited
in Modena (Po0.001).
3There was no significant difference in dermoscopy sensitivity (P=0.570)
for MM between Sydney and Modena-recruited lesions.
Table 4. Specificity for the diagnosis of MM of
dermoscopy and RCM as a function of nevus
histological type (study biopsied set)
Nevus (203)
Diagnosed
as benign by
dermoscopy
Diagnosed
as MM by
dermoscopy
Diagnosed
as benign
by RCM
Diagnosed
as MM by
RCM
Junctional (42) 8 34 33 9
19%1 81% 78.6%2 21.4%
Compound and
dermal (136)
53 83 101 35
39%1,3 61% 74.3%4 25.7%
Spitz (25) 4 21 4 21
16%2 84% 16%2,4 84%
MM, melanoma.
1There was a significant difference between the correct dermoscopy
classification (specificity for the diagnostic of MM) of junctional and
compound/dermal nevi (P=0.017).
2There was a significant difference between the RCM specificity for the
diagnosis of junctional and Spitz nevi (Po0.001).
3There was a significant difference between the correct dermoscopy
classification of the compound/dermal nevi and Spitz nevi (P=0.027).
4There was a significant difference between the RCM specificity for the
diagnosis of the compound/dermal nevi and Spitz nevi (Po0.001).
Table 5. The diagnostic impact of combining RCM and
dermoscopy diagnosis (study biopsied set)
Double negative1 Single positive2 Double positive3
Nevus (203) 46 111 46
22.7% 54.7% 22.7%
MM (123) 3 20 100
2.4% 16.3% 81.3%
Spearman’s r 0.1784
CI, confidence interval; MM, melanoma; OR, odds ratio; RCM, reflectance
confocal microscopy.
1Negative refers to a benign diagnosis. Positive refers to a diagnosis of MM.
2There were 8 (6.5%) MMs correctly identified by dermoscopy but
misclassified by RCM, and 12 (9.8%) MMs correctly identified by RCM
but misclassified by dermoscopy. There were 19 (9.4%) nevi correctly
identified by dermoscopy but diagnosed by RCM as MM compared with
92 (45.3%) nevi correctly identified by RCM but misclassified by
dermoscopy as MM.
3If at least one method was positive (single+double positive), the OR (95%
CI) for the diagnosis of MM was 11.7 (3.6–38.6). If the two methods were
positive (double positive), the OR (95% CI) was 14.8 (8.5–25).
4Correlation between dermoscopy and RCM diagnosis accuracy was
significant (Po0.01) but weak (r-value=0.178, Spearman’s test; Jackson
et al., 1980).
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with naked eye examination (Menzies and Zalaudek 2006),
this design would not lead to any understanding of the role of
RCM in the clinical arena. The specificity results for
dermoscopy are much lower than those reported elsewhere,
and this is entirely the result of the study design. Never-
theless, our results suggest that RCM has a role in the
secondary evaluation of lesions that have already been
determined to be suspicious by dermoscopy. Furthermore, on
a population of 100 non-suspicious nevi, the RCM specificity
was 100%, suggesting that an improvement in specificity
should be implementable in any general clinical setting.
We confirm that the Spitz nevi selected in this study are a
pitfall of the RCM method (Pellacani et al., 2005), All the
histologically proven Spitz nevi in the study were also
atypical under dermoscopy (Ferrara et al., 2005), which
failed to correctly classify these lesions in the same
proportion for both methods (21 out of 25 misclassified).
Because both pagetoid cells and architectural disarrangement
at the dermal–epidermal junction (corresponding to non-
edged papillae under RCM examination) are commonly seen,
at least centrally, in Spitz nevi (Barnhill et al., 1999), they
lead to a false-positive diagnosis using our RCM method. In
the future, it may be possible to develop an RCM diagnostic
method for Spitz nevi addressing these limitations.
Importantly, RCM examination was particularly accurate
for light-colored lesions as described in case reports (Busam
et al., 2001; Curiel-Lewandrowski et al., 2004). These lesions
are a well-known clinical and dermoscopy challenge (Bono
et al., 2001; Pizzichetta et al., 2004). They were more
frequent in the population recruited in Sydney than in
Modena, probably due to the greater predominance of
Anglo-Celtics in the former location. For light-colored
lesions, the sensitivity and specificity of the RCM method
were superior to dermoscopy (although only specificity
achieved statistical significance), perhaps due to a relatively
low sample size of light-colored MM). However, the RCM
method specificity was more than twofold superior to
dermoscopy for light-colored lesions. The improved diag-
nostic accuracy of RCM with light-colored lesions may be
explained by the fact that melanin appears very bright under
reflectance microscopy, even in very small quantities
(Rajadhyaksha et al., 1995). Indeed, immunohistochemical
and ultrastructural studies show that amelanotic MM cells
contained aberrant melanosomes and rare melanin granules
Table 6. Sensitivity and specificity of dermoscopy and RCM methods on light-colored versus pigmented
melanocytic lesions (study biopsied set)
Melanocytic lesions (326) Sensitivity dermoscopy Specificity dermoscopy Sensitivity RCM Specificity RCM
Light-colored 61.5%1 (8/13) 39%2,3 (12/31) 85%1 (11/13) 84%2,4 (26/31)
Pigmented 91%1 (100/110) 312,3 (53/172) 92%1 (101/110) 65%2,4 (112/172)
MM, melanoma.
1There was no significant difference in sensitivity between the two methods for either light-colored (P=0.09) or pigmented lesions (P=0.81).
2The specificity for the diagnosis of MM between dermoscopy and RCM methods was significantly different for both light-colored lesions (Po0.001) and
pigmented lesions (Po0.001).
3Using dermoscopy, there was no significant difference in specificity (P=0.456) for light-colored versus pigmented lesions, but there was a significant
increase in sensitivity for pigmented ones (P=0.02).
4Using RCM, there was a significant increase in specificity (Po0.05) but not in sensitivity (P=0.328) for the diagnosis of MM for light-colored versus
pigmented lesions.
a
b
Figure 3. Dermoscopy and RCM imaging. (a) Dermoscopy image of a
6-mm-diameter lesion on the arm of a 53-year-old man showing symmetrical
pattern leading to a benign diagnosis using Menzies’ method. Some areas
of dotted and linear irregular vessels may suggest a diagnosis of melanoma
using pattern analysis. (b) In vivo confocal microscopy image showing a large
atypical nucleated bright-pigmented cell (arrow) in a disorganized epidermis
and non-edged dermal papillae (arrowhead); RCM score¼4. Diagnosis:
amelanotic melanoma of 0.7mm Breslow thickness.
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(Erlandson, 1987; Gibson and Goellner, 1988). Such isolated
bright cells are easily visualized on a 44mm horizontal
section seen with RCM.
In clinical practice, because RCM provides a non-invasive
and immediate diagnosis, it can assist in the management of
suspicious lesions in a secondary care setting. As 5–10min-
utes are required for the RCM diagnosis of a single lesion, this
method is clearly not to be applied for first-level examination.
In the clinical scenario where both techniques will be
used, the weak correlation between RCM and dermoscopy
diagnoses, indicative of the very different morphological
features seen with the two techniques, allows a significant
improvement in sensitivity (98%) for the diagnosis of MM
when lesions are excised because of either RCM or
dermoscopy evidence of malignancy. Finally, we see RCM
altering the clinic in a number of fundamental ways. Firstly, if
clinically suspicious lesions were assessed for diagnosis
solely on RCM as a second-line examination in accordance
with the methods of recruiting those lesions as seen in our
study population, then a dramatic reduction in the rate of
excision of benign lesions (exceeding 50%) would occur.
Under these conditions, all RCM-negative lesions could
undergo digital monitoring to allow the detection of
misclassified MMs. Secondly, if clinically suspicious lesions
were assessed for diagnosis by combining RCM and dermo-
scopy, those classified as benign could be more confidently
observed because of the 98% sensitivity achieved. Here, a
reduction of 23% of excised suspect benign lesions would
occur. In conclusion, our data provide good evidence that
RCM enhances secondary evaluation of melanocytic lesions.
MATERIALS AND METHODS
Recruitment
Lesion recruitment was performed in two secondary care settings:
the Sydney Melanoma Diagnostic Centre, Australia, and the
Department of Dermatology, University of Modena, Italy.
Study population. In both institutions, all melanocytic lesions
recruited required excision following standard clinical practices.
Specifically, these related to dermoscopy examination, change
following sequential digital monitoring (Kittler et al., 2006), or
baseline photography, patient history, or combinations of these.
In Sydney, all lesions imaged with the RCM were included (25
lesions out of 156 were rejected for poor quality dermoscopy image,
blinded to the diagnostician). In Modena, all MMs imaged with the
RCM were included but 50% of nevi were randomly selected from
the image database prior to analysis to reduce the MM/nevus ratio.
To ensure a completely independent data set, no lesions used in
previous assessments or RCM model development (Pellacani et al.,
2005) were included in this study. Lentigo maligna and lesions of the
soles and palms were excluded because the RCM method previously
reported was not conducted on these lesions.
Non-biopsied population. RCM imaging of 100 lesions (50 from
Sydney and 50 from Modena) assessed as benign nevi on these
clinical grounds but not excised were taken from 28 volunteers.
These lesions were chosen to ensure variability in their dermoscopy
patterns.
This study was approved by the Ethics Committee in Sydney
(protocol number X05-0218) and the local Institutional Review
Board in Modena, and informed and signed consent was obtained
from all volunteers, according to the Declaration of Helsinki
Principles.
Population
Study population. The characteristics of the populations are
summarized in Table 1. The study population included 326 patients:
149 women, 177 men, median age of 47 years (interquartile 25 and
75% (IQ 25–75): 36–60), range 6–90 years of age with a total of 203
nevi (127 compound, 9 dermal, 42 junctional, and 25 Spitz), and
123 MMs, median Breslow thickness of 0.54mm (IQ 25–75: 0–0.98),
34 in situ, 86 superficial spreading, and 3 nodular MM. The color of
the lesion was evaluated by dermoscopy, classifying the lesion as
light-colored (comprising amelanotic lesions or those with tan, light
gray, or pale blue pigment only) and pigmented (comprising partially
or completely pigmented lesions with at least an area of dark brown,
black, blue, or gray pigment). The MMs comprised 13 light-colored
and 110 pigmented lesions, and nevi comprised 31 light-colored and
172 pigmented lesions. There were no significant differences in age,
sex, MM Breslow thickness, and histologic type between the Sydney
and Modena populations. However, there were significant differ-
ences in Spitz nevi (22 out of 25 were recruited in Modena,
P¼ 0.003) and light-colored lesions (25 and 7.8% of nevi, and 15.9
and 7.6% of MMs in the Sydney and the Modena populations,
respectively, Po0.05).
Non-biopsied population. A total of 100 benign nevi were
imaged from 28 volunteers aged between 27 and 53 years.
Instruments
Lesions recruited from Sydney were imaged prior to biopsy with a
high-resolution digital oil immersion dermoscopy camera (Sentry,
Polartechnics Ltd, Sydney, NSW, Australia). In Modena, dermoscopy
diagnosis was made at the time of the first consultation with a hand-
held dermoscope (Delta 10, Heine, Herrsching, Germany).
Prior to biopsy, RCM images were acquired by means of
reflectance confocal laser scanning microscopes (Vivascope 1000
and Vivascope 1500, Lucid Inc., Henrietta, NY), which use
an 830nm laser source. Instrument and acquisition procedures
are described elsewhere (Rajadhyaksha et al., 1995). Each image
corresponds to a horizontal section at a selected depth, with an
approximately 500 500 mm field of view, a lateral resolution of
1.0 mm, and an axial resolution of 3–5 mm. A sequence of montage
images was acquired for each lesion to explore a minimum
of 4 4mm horizontal field of view per lesion near the dermal–
epidermal junction. For large lesions not completely comprised
within the field of view, the device was centered on the lesion or on
the area with the most suspicious dermoscopic features for
malignancy. Confocal sections, beginning at the stratum corneum
and ending within the papillary dermis, were recorded at areas of
interest. No lesion was imaged at a depth greater than 250mm owing
to the physical limit of penetration/reflectance of light. More than
100 captured RCM images per lesion were recorded. Most of the
acquisition was done automatically by the scanner, allowing an
average time of approximately 5–10minutes to complete all the
imaging. Some differences between Vivascope 1000 and Vivascope
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1500 exist. The former is a more cumbersome instrument, as
4 4mm images required laborious reprocessing. Furthermore,
single capture images were slightly smaller in size, however,
showing a similar quality with respect to the Vivascope 1500. The
time to review the six criteria of the RCM method (shown below) of
all the confocal images of individual cases was estimated to be
2–5minutes.
Dermoscopy diagnosis
Dermoscopy diagnosis of Sydney lesions was made retrospectively
on the images in a random order, blinded to RCM and pathological
diagnosis but not to information of site and age, by a Modena expert
(GP) using pattern analysis (Pehamberger et al., 1993). In Modena,
dermoscopy diagnosis was made at the time of the first consultation
using a hand-held dermoscope prior to RCM examination by the
Modena expert (GP) with the same method (pattern analysis).
RCM diagnosis
The confocal images from Modena were scored by PG (located in
Sydney), whereas the images from Sydney were scored by GP
(located in Modena), retrospectively and blinded to dermoscopy and
pathological diagnosis, but not to information of site and age. RCM
images in all studies were viewed, opening codified folders
containing all the raw images acquired for the corresponding case
without any sort. The RCM method, described elsewhere (Pellacani
et al., 2005), was used to obtain a final diagnosis. In brief, six
diagnostic features were scored: non-edged papillae and cytological
atypia at the dermal–epidermal junction were given a score of 2
each, whereas the presence of round pagetoid cells intraepidermally,
widespread pagetoid infiltration in the epidermis, nucleated cells
found within the dermal papillae, and cerebriform nests in the
dermis all scored 1 each. A score greater than 3 corresponded to the
threshold for the diagnosis of MM. Ninety randomly selected lesions
(50 MMs and 40 nevi) were scored by both observers to assess the
interobserver concordance. A tutorial and training set, derived from
the cases employed in the previous study by GP (Pellacani et al.,
2005) and not included in the present one, was used to standardize
the review of confocal images.
Statistical analysis
Statistical evaluation was carried out using SPSS (version 12.0.0,
2003; SPSS Inc., Chicago, IL). Interobserver variability in the
interpretation of RCM method was computed using the K-statistic
including 95% CIs (Altman, 1991). Sensitivity and specificity of each
method (dermoscopy and RCM) were calculated and contrasted
using w2 statistics with log OR and 95% CIs. The Kruskal–Wallis test
was used to assess the difference in median Breslow thickness of
MMs. The correlation between dermoscopy and RCM diagnosis was
calculated with Spearman’s r-test. r indicates the strength of the
linear relationship between the ranks of two variables. Similar to the
Pearson correlation coefficient, the rank correlation ranges between
1 and þ 1, corresponding to a perfect linear relationship for 1 and
no linear relationship for 0, and a positive or negative slope for
positive and negative values, respectively (Jackson, 1980).
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